David H. Gutmann

61.0k citations

556 papers · 33.8k indexed · 10 hit papers · h-index 97

Impact in

Neurology top 0.01%
- Neurofibromatosis and Schwannoma Cases
- Neuroblastoma Research and Treatments
- Vascular Malformations Diagnosis and Treatment
- Neuroinflammation and Neurodegeneration Mechanisms
Genetics top 0.05%
- Glioma Diagnosis and Treatment

Papers in

Neurology 360
- Neurofibromatosis and Schwannoma Cases 344
- Neuroblastoma Research and Treatments 134
- Vascular Malformations Diagnosis and Treatment 70
Genetics 114
- Glioma Diagnosis and Treatment 109

Co-authors: Rosalie E. Ferner Helmut Kettenmann Arie Perry Dolores Hambardzumyan Allison A. King Francis S. Collins Robert Listernick Michael Wong
Journals: Neuro-Oncology (26 papers)Cancer Research (25 papers)Neurology (22 papers)Oncogene (20 papers)Human Molecular Genetics (19 papers)
Partner nations: United States Germany Canada

In The Last Decade

David H. Gutmann

536 papers receiving 33.2k citations

Hit Papers

10 papers align trajectories log scale

Cancer neuroscience: State of the field, emerging directions 2023 · 243 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Cell
2017 Cancer Research
2017 Nature Reviews Disease Primers
2015 Nature Neuroscience
2014 The Lancet Neurology
2008 Nature Neuroscience
2008 PEDIATRICS
2000 Neurology
1997 JAMA
1992 Nature

Peers

Countries citing papers authored by David H. Gutmann

Since Specialization

Citations

This map shows the geographic impact of David H. Gutmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Gutmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Gutmann more than expected).

Fields of papers citing papers by David H. Gutmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Gutmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Gutmann. The network helps show where David H. Gutmann may publish in the future.

Co-authors

The 25 scholars most cited alongside David H. Gutmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David H. Gutmann Line = papers co-authored together David H. Gutmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cognition and behavior in neurofibromatosis type 1: report and perspective from the Cognition and Behavior in NF1 (CABIN) Task Force Genes & Development ·David H. Gutmann, Corina Anastasaki, Aditi Gupta, Yang Hou, Stephanie M. Morris, Jonathan M. Payne, Jacob Raber, Seth M. Tomchik, Linda Van Aelst, James A. Walker, Kaleb Yohay, (unknown)	2025	1
2	Examining Sex Differences in Autism Heritability JAMA Psychiatry ·Sven Sandin, Benjamin Hon Kei Yip, Weiyao Yin, Lauren A. Weiss, Joseph Dougherty, Stuart B. Fass, John N. Constantino, Hailin Zhu, Tychele N. Turner, Natasha Marrus, David H. Gutmann, Stephan Sanders, Benjamin Christoffersson	2024	11
3	Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1‐associated optic pathway gliomas in children Pediatric Blood & Cancer ·Nicole J. Ullrich, Sanjay P. Prabhu, Roger J. Packer, Stewart Goldman, Nathan Robison, Jeffrey C. Allen, David Viskochil, David H. Gutmann, John P. Perentesis, Bruce R. Korf, Michael J. Fisher, Mark W. Kieran	2020	13
4	Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma Clinical Cancer Research ·Angela C. Hirbe, Sonika Dahiya, Christopher A. Miller, Tiandao Li, Robert S. Fulton, Xiaochun Zhang, Sandra McDonald, Katherine DeSchryver, Eric J. Duncavage, Jessica C. Walrath, Karlyne M. Reilly, Haley Abel, Melike Pekmezci, Arie Perry, Timothy J. Ley, David H. Gutmann	2015	37
5	Suppression of MicroRNA-9 by Mutant EGFR Signaling Upregulates FOXP1 to Enhance Glioblastoma Tumorigenicity Cancer Research ·German G. Gomez, Stefano Volinia, Carlo M. Croce, Ciro Zanca, Ming Li, Ryan J. Emnett, David H. Gutmann, Cameron Brennan, Frank B. Furnari, Webster K. Cavenee	2014	61
6	Interpreting Mammalian Target of Rapamycin and Cell Growth Inhibition in a Genetically Engineered Mouse Model of Nf1 -Deficient Astrocytes Molecular Cancer Therapeutics ·Sutapa Banerjee, Scott M. Gianino, Feng Gao, Uwe Christians, David H. Gutmann	2011	33
7	Array-Based Comparative Genomic Hybridization Identifies CDK4 and FOXM1 Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor Clinical Cancer Research ·Jinsheng Yu, Hrishikesh Deshmukh, Jacqueline E. Payton, Christopher Dunham, Bernd W. Scheithauer, Tarık Tihan, Richard A. Prayson, Abhijit Guha, Julia A. Bridge, Rosalie E. Ferner, Guy Lindberg, Rebecca J. Gutmann, Ryan J. Emnett, Lorena Salavaggione, David H. Gutmann, Rakesh Nagarajan, Mark A. Watson, Arie Perry	2011	85
8	Cyclic AMP Suppression Is Sufficient to Induce Gliomagenesis in a Mouse Model of Neurofibromatosis-1 Cancer Research ·Nicole M. Warrington, Scott M. Gianino, Erin Jackson, Patricia Goldhoff, Joel R. Garbow, David Piwnica‐Worms, David H. Gutmann, Joshua B. Rubin	2010	87
9	The Neurofibromatosis Type 1 Tumor Suppressor Controls Cell Growth by Regulating Signal Transducer and Activator of Transcription-3 Activity In vitro and In vivo Cancer Research ·Sutapa Banerjee, Jonathan N. Byrd, Scott M. Gianino, Scott E. Harpstrite, Fausto J. Rodríguez, Robert G. Tuskan, Karlyne M. Reilly, David Piwnica‐Worms, David H. Gutmann	2010	49
10	Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas Cancer Research ·Joshua D. Schiffman, John Hodgson, Scott R. VandenBerg, Patrick Flaherty, Mei‐Yin C. Polley, Mamie Yu, Paul G. Fisher, David H. Rowitch, James M. Ford, Mitchel S. Berger, Hanlee P. Ji, David H. Gutmann, C. David James	2010	185
11	Increased c-Jun-NH2-Kinase Signaling in Neurofibromatosis-1 Heterozygous Microglia Drives Microglia Activation and Promotes Optic Glioma Proliferation Cancer Research ·Girish Daginakatte, Scott M. Gianino, Nina W. Zhao, Alexander Parsadanian, David H. Gutmann	2008	91
12	Merlin Is a Potent Inhibitor of Glioma Growth Cancer Research ·Ying-Ka Ingar Lau, Lucas B. Murray, Sean S. Houshmandi, Xu Yin, David H. Gutmann, Qin Yu	2008	88
13	Distinct Genetic Signatures among Pilocytic Astrocytomas Relate to Their Brain Region Origin Cancer Research ·Mukesh Kumar Sharma, David B. Mansur, Guido Reifenberger, Arie Perry, Jeffrey R. Leonard, Kenneth Aldape, Meredith G. Albin, Ryan J. Emnett, Simon Loeser, Mark A. Watson, Rakesh Nagarajan, David H. Gutmann	2007	125
14	Nucleophosmin Mediates Mammalian Target of Rapamycin–Dependent Actin Cytoskeleton Dynamics and Proliferation in Neurofibromin-Deficient Astrocytes Cancer Research ·Danielle K. Sandsmark, Huabiao Zhang, Balázs Hegedűs, Corey Pelletier, Jason D. Weber, David H. Gutmann	2007	52
15	Spatiotemporal Differences in CXCL12 Expression and Cyclic AMP Underlie the Unique Pattern of Optic Glioma Growth in Neurofibromatosis Type 1 Cancer Research ·Nicole M. Warrington, B. Mark Woerner, Girish Daginakatte, Biplab Dasgupta, Arie Perry, David H. Gutmann, Joshua B. Rubin	2007	87
16	Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein Proceedings of the National Academy of Sciences ·Deborah Chadee, Da-Zhong Xu, Gene Hung, Ali Andalibi, David Lim, Zhijun Luo, David H. Gutmann, John Kyriakis	2006	78
17	Protein 4.1B/Differentially Expressed in Adenocarcinoma of the Lung-1 Functions as a Growth Suppressor in Meningioma Cells by Activating Rac1-Dependent c-Jun-NH2-kinase Signaling Cancer Research ·Mark A. Gerber, Scott M. Bahr, David H. Gutmann	2006	33
18	Large-Scale Molecular Comparison of Human Schwann Cells to Malignant Peripheral Nerve Sheath Tumor Cell Lines and Tissues Cancer Research ·Shyra J. Miller, Fatima Rangwala, Jon Williams, Peter Ackerman, Sue Kong, Anil G. Jegga, Sérgio Kaiser, Bruce J. Aronow, Silke Frahm, Lan Kluwe, Victor Mautner, Meena Upadhyaya, David Muir, Margaret R. Wallace, Jussara Hagen, Dawn E. Quelle, Mark A. Watson, Arie Perry, David H. Gutmann, Nancy Ratner	2006	158
19	Glioma Formation in Neurofibromatosis 1 Reflects Preferential Activation of K-RAS in Astrocytes Cancer Research ·Biplab Dasgupta, Wen Li, Arie Perry, David H. Gutmann	2005	74
20	Pten Loss Causes Hypertrophy and Increased Proliferation of Astrocytes *In vivo* Cancer Research ·Melissa M. Fraser, Xiaoyan Zhu, Chang-Hyuk Kwon, Erik J. Uhlmann, David H. Gutmann, Suzanne J. Baker	2004	183

About David H. Gutmann

David H. Gutmann is a scholar working on Neurology, Genetics, Developmental Neuroscience, Epidemiology and Neurology, having authored 556 papers that have together received 33.8k indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (344 papers), Meningioma and schwannoma management (137 papers), Neuroblastoma Research and Treatments (134 papers), Glioma Diagnosis and Treatment (109 papers), Vascular Malformations Diagnosis and Treatment (70 papers), Sarcoma Diagnosis and Treatment (49 papers), Chromatin Remodeling and Cancer (34 papers) and Tuberous Sclerosis Complex Research (33 papers). The work is most often cited by research in Neurology (17.2k citations), Genetics (6.3k citations), Neurology (2.5k citations), Developmental Neuroscience (1.3k citations) and Epidemiology (7.2k citations). David H. Gutmann has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Rosalie E. Ferner, Helmut Kettenmann, Arie Perry, Dolores Hambardzumyan, Allison A. King, Francis S. Collins, Robert Listernick, Michael Wong, Scott M. Gianino and Bruce R. Korf. Their work appears in journals such as Neuro-Oncology, Cancer Research, Neurology, Oncogene and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact